| Ultrasound targeted microbubble destruction for drug and gene delivery CR Mayer, NA Geis, HA Katus, R Bekeredjian Expert opinion on drug delivery 5 (10), 1121-1138, 2008 | 180 | 2008 |
| New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization S Tinkov, C Coester, S Serba, NA Geis, HA Katus, G Winter, ... Journal of Controlled Release 148 (3), 368-372, 2010 | 174 | 2010 |
| Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives NA Geis, HA Katus, R Bekeredjian Current pharmaceutical design 18 (15), 2166-2183, 2012 | 119 | 2012 |
| One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip© implantation ST Pleger, M Schulz‐Schönhagen, N Geis, D Mereles, E Chorianopoulos, ... European journal of heart failure 15 (8), 919-927, 2013 | 90 | 2013 |
| Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage S Horstmann, C Zugck, U Krumsdorf, T Rizos, G Rauch, N Geis, S Hardt, ... Neurology 82 (2), 135-138, 2014 | 79 | 2014 |
| Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve … NA Geis, M Puls, E Lubos, CS Zuern, J Franke, R Schueler, ... European journal of heart failure 20 (3), 598-608, 2018 | 75 | 2018 |
| Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack S Zell, N Geis, R Rutz, S Schultz, T Giese, M Kirschfink Clinical & Experimental Immunology 150 (3), 576-584, 2007 | 71 | 2007 |
| Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro N Geis, S Zell, R Rutz, W Li, T Giese, S Mamidi, S Schultz, M Kirschfink Current cancer drug targets 10 (8), 922-931, 2010 | 63 | 2010 |
| Improvements of procedural results with a new‐generation self‐expanding transfemoral aortic valve prosthesis in comparison to the old‐generation device B Gomes, NA Geis, E Chorianopoulos, B Meder, F Leuschner, HA Katus, ... Journal of interventional cardiology 30 (1), 72-78, 2017 | 61 | 2017 |
| First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome MI MURRAY, N Geis, ST Pleger, K Kallenbach, HA Katus, R Bekeredjian, ... Journal of interventional cardiology 28 (1), 109-116, 2015 | 59 | 2015 |
| NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation NA Geis, C Kiriakou, E Chorianopoulos, L Uhlmann, HA Katus, ... Clinical Research in Cardiology 107, 799-806, 2018 | 56 | 2018 |
| Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis E Chorianopoulos, U Krumsdorf, N Geis, ST Pleger, E Giannitsis, ... Clinical research in cardiology 103, 65-72, 2014 | 50 | 2014 |
| Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair NA Geis, ST Pleger, E Chorianopoulos, OJ Müller, HA Katus, ... EuroIntervention 10 (11), 1346-1353, 2015 | 46 | 2015 |
| Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation. NA Geis, C Kiriakou, E Chorianopoulos, ST Pleger, HA Katus, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2017 | 44 | 2017 |
| Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability NA Geis, CR Mayer, RD Kroll, SE Hardt, HA Katus, R Bekeredjian Ultrasound in medicine & biology 35 (7), 1119-1126, 2009 | 37 | 2009 |
| Haemodynamic effects of percutaneous mitral valve edge‐to‐edge repair in patients with end‐stage heart failure awaiting heart transplantation NA Geis, ST Pleger, R Bekeredjian, E Chorianopoulos, MM Kreusser, ... ESC heart failure 5 (5), 892-901, 2018 | 23 | 2018 |
| Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: results from a prospective European multicenter study SE Hardt, A Eicken, F Berger, S Schubert, M Carminati, G Butera, ... Catheterization and Cardiovascular Interventions 90 (5), 824-829, 2017 | 23 | 2017 |
| One‐year results following PASCAL‐based or MitraClip‐based mitral valve transcatheter edge‐to‐edge repair NA Geis, P Schlegel, MB Heckmann, HA Katus, N Frey, P Crespo López, ... ESC heart failure 9 (2), 853-865, 2022 | 21 | 2022 |
| The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre-and postinterventional cardiac computed … R Bekeredjian, D Bodingbauer, NP Hofmann, S Greiner, M Schuetz, ... The Journal of invasive cardiology 27 (3), 172-180, 2015 | 21 | 2015 |
| Peri‐procedural silent cerebral infarcts after left atrial appendage occlusion M Laible, M Möhlenbruch, S Horstmann, J Pfaff, NA Geis, S Pleger, ... European journal of neurology 24 (1), 53-57, 2017 | 20 | 2017 |
